Mark Baum is a distinguished determine within the trade global, recognized for his luck because the Leader Govt Officer and Director of Harrow Well being. Many are concerned about his web value and monetary achievements. Let’s delve into the main points and discover simply how a lot Mark Baum is value.
Key Takeaways:
- Mark Baum has an estimated web value of no less than $19.7 million greenbacks.
- He owns over 7,500 devices of Harrow Well being inventory value over $18,125,731.
- Baum has offered HROW inventory value over $219,135 within the closing 10 years.
- Because the CEO and Director of Harrow Well being, he earns a complete repayment of $1,377,010.
- Baum is fascinated about different trade ventures and is a founder and board member of a number of pharmaceutical corporations.
Mark Baum Inventory Buying and selling Historical past
Mark Baum, the Leader Govt Officer and Director of Harrow Well being, has been actively fascinated about inventory buying and selling over time. His buying and selling historical past finds a strategic means and a deep working out of the marketplace. Since 2015, Baum has revamped 13 trades of Harrow Well being inventory, showcasing his self belief within the corporate’s efficiency.
| Date | Sort | Devices | Price |
|---|---|---|---|
| November 16, 2023 | Purchase | 7,500 | $60,825 |
| April 25, 2021 | Workout | 850,000 | $7,616,000 |
The newest business made via Baum was once on November 16, 2023, when he bought 7,500 devices of Harrow Well being inventory value $60,825. This transaction displays his optimism within the corporate’s long run expansion. Then again, his greatest business thus far was once on April 25, 2021, when he exercised 850,000 devices of Harrow Well being inventory, valued at an outstanding $7,616,000.
On moderate, Mark Baum trades round 85,878 devices of Harrow Well being inventory each 101 days since 2013. This constant process demonstrates his dedication to strategic decision-making and his self belief within the corporate’s long-term potentialities.
Mark Baum’s inventory buying and selling historical past exemplifies his experience out there and displays his trust in Harrow Well being’s possible for luck.
Mark Baum Biography and Occupation
Mark L. Baum, J.D., serves because the Leader Govt Officer and Director of Harrow Well being. He’s a extremely a hit and influential determine within the healthcare trade. With a background as a U.S. securities attorney, Baum has been instrumental within the restructuring and reorganization of Harrow Well being, main the corporate to its present standing as a extremely a hit ophthalmic-focused healthcare corporate.
Previous to his function at Harrow Well being, Baum based and controlled TBLF, LLC, a consulting company and fund supervisor. His intensive enjoy within the pharmaceutical trade has additionally led him to turn out to be a founder and board member of a number of different pharmaceutical corporations, together with Eton Prescribed drugs, Inc., Floor Prescribed drugs, Inc., Soften Prescribed drugs, Inc., and subsidiaries Mayfield Prescribed drugs, Inc., and Radley Prescribed drugs, Inc.
Baum’s experience and management have performed a vital function within the expansion and luck of Harrow Well being. Underneath his steering, the corporate has completed exceptional milestones, making a vital affect within the ophthalmology outsourcing and pharmaceutical compounding trade. Along with his huge wisdom and enjoy, Baum continues to give a contribution to the development of the healthcare trade.
Mark Baum’s Occupation Highlights:
- Leader Govt Officer and Director of Harrow Well being
- Founder and Board Member of TBLF, LLC
- Founder and Board Member of Eton Prescribed drugs, Inc.
- Founder and Board Member of Floor Prescribed drugs, Inc.
- Founder and Board Member of Soften Prescribed drugs, Inc.
- Founder and Board Member of Mayfield Prescribed drugs, Inc. and Radley Prescribed drugs, Inc. (subsidiaries)
“Mark Baum’s management and experience had been valuable in riding Harrow Well being’s luck and expansion. His huge enjoy within the pharmaceutical trade has located the corporate as a pacesetter in ophthalmic healthcare. Baum’s contributions proceed to form the way forward for the trade.”
Mark Baum Wage and Repayment
Because the Leader Govt Officer and Director of Harrow Well being, Mark Baum earns a complete repayment of $1,377,010. He’s the highest-paid govt on the corporate.
Mark Baum’s wage and repayment replicate his place as a key chief within the group. His tasks as CEO and Director come with overseeing the corporate’s operations, making strategic selections, and riding its expansion and luck.
It’s value noting that Mark Baum’s repayment is in keeping with his contributions to Harrow Well being and the price he brings to the corporate. As CEO, he performs a an important function in riding the corporate’s efficiency and reaching its monetary targets.
Total, Mark Baum’s wage and repayment replicate his place as a most sensible govt and his vital affect at the luck of Harrow Well being.
| Place | Wage | Bonus | Inventory Awards | Overall Repayment |
|---|---|---|---|---|
| CEO and Director | $1,377,010 | $0 | $0 | $1,377,010 |
Notice: The above desk represents Mark Baum’s wage and repayment because the CEO and Director of Harrow Well being. The full repayment comprises wage, bonuses, and inventory awards.
Mark Baum Insider Buying and selling at Harrow Well being
Insider buying and selling refers back to the purchasing or promoting of an organization’s inventory via people who have get right of entry to to personal details about the corporate. Mark Baum, the Leader Govt Officer and Director of Harrow Well being, has made a number of insider trades on the corporate, offering insights into his funding selections and sentiment.
Over the past 5 years, insiders at Harrow Well being, together with Mark Baum, have traded over $1,363,111 value of Harrow Well being inventory. Those trades contain each purchasing and promoting of stocks, indicating Baum’s lively involvement in managing his funding portfolio.
“Insider buying and selling may give treasured details about an organization’s potentialities and the boldness its executives have in its long run,” says Baum.
As of the newest to be had knowledge, Mark Baum nonetheless owns no less than 2,022,961 devices of Harrow Well being inventory. This means a endured trust within the corporate’s expansion possible and a long-term dedication to its luck.
| Date | Sort | Stocks Traded | Value in line with Percentage | Price |
|---|---|---|---|---|
| November 16, 2023 | Purchase | 7,500 | $8.11 | $60,825 |
| April 25, 2021 | Workout | 850,000 | N/A | $7,616,000 |
Mark Baum’s insider buying and selling actions at Harrow Well being supply treasured insights for traders, losing mild on his self belief within the corporate’s long run and possible expansion.
Mark Baum’s Different Industry Ventures
With the exception of his function at Harrow Well being, Mark Baum is actively fascinated about a number of different pharmaceutical corporations. Baum is a founder and board member of Eton Prescribed drugs, Inc., Floor Prescribed drugs, Inc., Soften Prescribed drugs, Inc., and subsidiaries Mayfield Prescribed drugs, Inc., and Radley Prescribed drugs, Inc. Along with his intensive enjoy and experience within the trade, Baum performs a vital function in shaping the luck and expansion of those corporations.
Mark Baum’s involvement in a couple of pharmaceutical ventures showcases his willpower and dedication to advancing healthcare answers. Those corporations paintings in opposition to growing leading edge pharmaceutical merchandise, contributing to the advance of affected person results and addressing unmet scientific wishes. Baum’s strategic steering and management give a contribution to the luck of those ventures, additional solidifying his recognition as a distinguished determine within the pharmaceutical trade.
Mark Baum’s lively involvement in quite a lot of pharmaceutical corporations demonstrates his dedication to compelling innovation and discovering answers to healthcare demanding situations. His contributions to Eton Prescribed drugs, Floor Prescribed drugs, Soften Prescribed drugs, Mayfield Prescribed drugs, and Radley Prescribed drugs spotlight his talent to spot promising alternatives and lead a hit ventures throughout the pharmaceutical sector.
Mark Baum’s numerous trade ventures within the pharmaceutical trade exemplify his entrepreneurial spirit and fervour for making a favorable affect. Via his involvement in those corporations, Baum continues to force innovation, foster collaboration, and give a contribution to developments within the box of healthcare.
Eton Prescribed drugs, Inc.
Eton Prescribed drugs, Inc. is a pharmaceutical corporate desirous about bettering affected person results during the building and commercialization of leading edge merchandise. With Mark Baum as a founder and board member, Eton Prescribed drugs is poised for luck in bringing treasured drugs to the marketplace.
Floor Prescribed drugs, Inc.
Floor Prescribed drugs, Inc. is dedicated to growing novel therapeutics to deal with important unmet scientific wishes. Mark Baum’s function as a founder and board member contributes to the corporate’s project of bettering affected person care and high quality of lifestyles.
Soften Prescribed drugs, Inc.
Soften Prescribed drugs, Inc. specializes in the advance and production of leading edge oral skinny movies for the supply of pharmaceutical merchandise. With Mark Baum’s involvement, the corporate objectives to revolutionize drug supply strategies and reinforce affected person comfort and compliance.
Mayfield Prescribed drugs, Inc.
Mayfield Prescribed drugs, Inc. is devoted to finding and growing leap forward therapies throughout quite a lot of healing spaces. Mark Baum’s function as a founder and board member underscores the corporate’s dedication to advancing healthcare answers and bettering affected person results.
Radley Prescribed drugs, Inc.
Radley Prescribed drugs, Inc. is a pharmaceutical corporate targeted at the analysis and building of novel therapeutics. Mark Baum’s contributions as a founder and board member improve the corporate’s project to deal with unmet scientific wishes and force innovation within the pharmaceutical trade.
Mark Baum’s involvement in those numerous trade ventures highlights his profound affect at the pharmaceutical trade, in addition to his willpower to advancing healthcare and bettering affected person results.
Harrow Well being Assessment
Harrow Well being, Inc. is a number one ophthalmic-focused healthcare corporate that focuses on offering leading edge answers within the ophthalmology sector. The corporate owns ImprimisRx, a famend outsourcing and pharmaceutical compounding trade that caters in particular to the wishes of ophthalmologists. With an unwavering dedication to excellence, Harrow Well being strives to offer remarkable services that reinforce affected person care and beef up remedy results.
As a pharmaceutical corporate, Harrow Well being now not handiest specializes in its core trade but in addition holds fairness pursuits in different pharmaceutical corporations. This strategic diversification lets in the corporate to leverage its experience and sources to amplify its succeed in within the healthcare trade.
“We consider that each affected person merits get right of entry to to fine quality, inexpensive ophthalmic drugs and customized remedy choices. Our function is to revolutionize the ophthalmology sector via introducing leading edge answers that cope with the original demanding situations and wishes of healthcare execs and sufferers,” stated Mark Baum, CEO and Director of Harrow Well being.
Harrow Well being was once in the past referred to as Imprimis Prescribed drugs, Inc. sooner than rebranding itself as Harrow Well being, Inc. in 2018. The corporate has a powerful presence within the ophthalmology box and continues to discover new avenues for expansion and growth.
| Based | Specialization | Fairness Pursuits |
|---|---|---|
| In 2012 | Ophthalmology | A couple of Pharmaceutical Corporations |
Key Executives and Insiders at Harrow Well being
As a number one ophthalmic-focused healthcare corporate, Harrow Well being is pushed via a powerful and succesful management group. The important thing executives at Harrow Well being play a pivotal function in shaping the corporate’s strategic route and riding its luck. Let’s take a better have a look at the important thing executives and insiders who give a contribution to the expansion and building of Harrow Well being.
Harrow Well being Executives
1. Mark Baum – CEO and Director:
Mark Baum serves because the Leader Govt Officer and Director of Harrow Well being. Along with his intensive enjoy and experience, Baum has been instrumental in main the restructuring and reorganization of the corporate since 2011. His strategic imaginative and prescient and management talents had been important in riding Harrow Well being’s expansion and luck.
2. Andrew Boll – CFO, Company Secretary:
Andrew Boll is the Leader Monetary Officer and Company Secretary of Harrow Well being. Along with his monetary acumen and experience, Boll performs a an important function in managing the corporate’s monetary operations and making sure its monetary steadiness. His contributions are integral to Harrow Well being’s general monetary efficiency.
Harrow Well being Insiders
Harrow Well being insiders are people who have a deep working out of the corporate and its operations. Those insiders give a contribution to the total luck of the corporate via their treasured insights and experience. Whilst there are a number of administrators and unbiased board participants at Harrow Well being, it’s value highlighting the next:
1. John Saharek – President of ImprimisRx:
John Saharek serves because the President of ImprimisRx, Harrow Well being’s ophthalmology outsourcing and pharmaceutical compounding trade. Along with his intensive wisdom of the ophthalmic trade, Saharek performs an important function in riding the luck of ImprimisRx and making sure the supply of fine quality services to consumers.
In the course of the collective efforts of those key executives and insiders, Harrow Well being continues to thrive as a number one participant within the healthcare trade, offering leading edge answers to fulfill the wishes of sufferers and healthcare execs alike.
Mark Baum’s Holdings and Possession Abstract
Mark Baum, the Leader Govt Officer and Director of Harrow Well being, holds vital inventory holdings in a couple of corporations. His funding portfolio is composed of 3 major shares: Harrow Well being, Eton Prescribed drugs, and Splendid Energy. Those holdings supply insights into Baum’s numerous funding technique and his involvement within the pharmaceutical and effort sectors.
Harrow Well being:
As of the newest to be had knowledge, Baum owns 2,022,961 stocks of Harrow Well being. This really extensive stake demonstrates his self belief within the corporate’s long run potentialities and its possible for expansion within the ophthalmic healthcare trade. Harrow Well being, previously referred to as Imprimis Prescribed drugs, is a longtime participant out there, proudly owning ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding trade.
Eton Prescribed drugs:
Baum additionally holds 794,745 stocks of Eton Prescribed drugs, Inc., additional diversifying his funding portfolio throughout the pharmaceutical sector. Eton Prescribed drugs specializes in growing and commercializing leading edge drug merchandise that cope with unmet scientific wishes. Baum’s possession in Eton Prescribed drugs signifies his passion in supporting the development of healthcare answers.
Splendid Energy:
Along with his pharmaceutical investments, Mark Baum holds 2,906 stocks of Splendid Energy, an organization running within the power sector. Splendid Energy focuses on the advance and commercialization of complicated energy conversion applied sciences. Baum’s possession in Splendid Energy highlights his involvement in sustainable power answers and his reputation of the significance of the power trade in riding world innovation.
Mark Baum’s inventory holdings in Harrow Well being, Eton Prescribed drugs, and Splendid Energy jointly give a contribution to his estimated web value of no less than $15.2 million. Those investments reveal his dedication to numerous sectors and his trust in the potential for those corporations to ship long-term worth to traders.
| Inventory | Collection of Stocks |
|---|---|
| Harrow Well being | 2,022,961 |
| Eton Prescribed drugs | 794,745 |
| Splendid Energy | 2,906 |
Michael Burry and The Large Quick
Along with the fictitious personality Mark Baum, there’s any other notable determine related to “The Large Quick” – Michael Burry. Burry’s tale become well-known for his fantastic luck in making a bet in opposition to the housing marketplace. The ebook and movie adaptation of “The Large Quick” make clear his exceptional adventure.
Michael Burry, an investor with a willing eye for recognizing tendencies, identified early at the instability within the housing marketplace. He noticed the issues and dangers throughout the mortgage-backed securities that had been being extensively traded. Burry had the foresight to are expecting the upcoming cave in and made a daring transfer to wager in opposition to those securities.
His conviction paid off vastly when the monetary disaster hit. Burry’s funding technique earned him really extensive income whilst many others suffered vital losses. His tale serves as a reminder of the significance of important pondering and thorough research within the monetary global.
The depiction of Michael Burry’s exceptional adventure in “The Large Quick” supplies a fascinating perception into the sector of finance and the occasions main as much as the 2008 world monetary disaster.
FAQ
How a lot is Mark Baum value?
Mark Baum has an estimated web value of no less than $19.7 million greenbacks as of November 16, 2023.
What’s Mark Baum’s inventory buying and selling historical past?
Mark Baum has revamped 13 trades of Harrow Well being inventory since 2015. His most up-to-date business was once purchasing 7,500 devices of HROW inventory value $60,825 on November 16, 2023.
What’s Mark Baum’s biography and profession?
Mark L. Baum, J.D., serves because the Leader Govt Officer and Director of Harrow Well being. He led the restructuring and reorganization of Harrow in 2011 and has been instrumental in its expansion since then.
How a lot is Mark Baum’s wage and repayment?
Mark Baum makes $1,377,010 because the Leader Govt Officer and Director at Harrow Well being. He’s the highest-paid govt on the corporate.
Has Mark Baum been fascinated about insider buying and selling at Harrow Well being?
Mark Baum has made a number of insider trades at Harrow Well being, purchasing and promoting inventory. Over the past 5 years, insiders at Harrow Well being have traded over $1,363,111 value of Harrow Well being inventory.
What different trade ventures is Mark Baum fascinated about?
But even so his function at Harrow Well being, Mark Baum is a founder and board member of a number of different pharmaceutical corporations, together with Eton Prescribed drugs, Inc., Floor Prescribed drugs, Inc., Soften Prescribed drugs, Inc., and subsidiaries Mayfield Prescribed drugs, Inc., and Radley Prescribed drugs, Inc.
Are you able to supply an outline of Harrow Well being?
Harrow Well being, Inc. is an ophthalmic-focused healthcare corporate that owns ImprimisRx, an ophthalmology outsourcing and pharmaceutical compounding trade. It additionally holds fairness pursuits in different pharmaceutical corporations.
Who’re the important thing executives and insiders at Harrow Well being?
The important thing executives at Harrow Well being come with Mark Baum (CEO and Director), Andrew Boll (CFO, Company Secretary), and John Saharek (President of ImprimisRx). There are a number of different administrators and unbiased board participants on the corporate.
What shares does Mark Baum these days personal?
Mark Baum these days owns a complete of three shares, together with Harrow Well being, Eton Prescribed drugs, and Splendid Energy.
What’s the connection between Michael Burry and The Large Quick?
Whilst Mark Baum is a fictional personality in keeping with actual particular person Steve Eisman, it’s value citing Michael Burry in the case of The Large Quick. Burry is any other investor who made a fortune via making a bet in opposition to the housing marketplace. His tale was once famously depicted within the ebook and movie adaptation of The Large Quick.
